In Alzheimer's disease Mentadem 5mg Tablet improves learning, memory and information processing (cognitive function) in people with mild to moderate Alzheimer's disease. These problems in memory and thinking may start interfering with daily activities and worsen your condition. This medicine will help in managing Alzheimer’s disease effectively. It will make it easier for you to carry out your daily activities and improve your quality of life. Do not stop taking it unless advised by the doctor. It can take several weeks for your symptoms to improve; so keep using the medicine even if you do not think it is working.
Caution is advised when consuming alcohol with Mentadem 5mg Tablet. Please consult your doctor.
Mentadem 5mg Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Information regarding the use of Mentadem 5mg Tablet during breastfeeding is not available. Please consult your doctor.
Mentadem 5mg Tablet may cause side effects which could affect your ability to drive.
Mentadem 5mg Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Mentadem 5mg Tablet may be needed. Please consult your doctor.
Mentadem 5mg Tablet should be used with caution in patients with severe liver disease. Dose adjustment of Mentadem 5mg Tablet may be needed. Please consult your doctor. Limited information is available on the use of Mentadem 5mg Tablet in these patients. No dose adjustment is recommended in patients with mild to moderate liver disease.
If you miss a dose of Mentadem 5mg Tablet, skip it and continue with your normal schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Sun Pharmaceutical Industries Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Zydus Cadila || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: East West Pharma || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Sun Pharmaceutical Industries Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Alteus Biogenics Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Care Formulation Labs Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Sun Pharmaceutical Industries Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Cellgen Biopharma || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Cortina Laboratories Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: La Renon Healthcare Pvt Ltd || ₹14.5/tablet (25% cheaper)